ReviewAnnals of hematology2023

Anti-CD30 antibody-drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives.

H Miles Prince et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.